Risk factors for Fontan-associated hepatocellular carcinoma
<h4>Aims</h4> The incidence of hepatocellular carcinoma (HCC) in patients with Fontan-associated liver disease (i.e., FALD-HCC) has increased over time. However, the risk factors for HCC development remain unclear. Here, we compared the levels of non-invasive markers to the survival rate...
Main Authors: | Tomomi Kogiso, Takaomi Sagawa, Makiko Taniai, Eriko Shimada, Kei Inai, Tokuko Shinohara, Katsutoshi Tokushige |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2022-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205474/?tool=EBI |
Similar Items
-
Risk factors for Fontan-associated hepatocellular carcinoma.
by: Tomomi Kogiso, et al.
Published: (2022-01-01) -
Risk and protective factors of acute kidney injury in decompensated cirrhotic patients with ascites on tolvaptan
by: Tomomi Kogiso, et al.
Published: (2021-11-01) -
Impact of continued administration of tolvaptan on cirrhotic patients with ascites
by: Tomomi Kogiso, et al.
Published: (2018-12-01) -
Analysis of genetic factors associated with fatty liver disease‐related hepatocellular carcinoma
by: Tomomi Kogiso, et al.
Published: (2023-09-01) -
Serum level of full-length connective tissue growth factor reflects liver fibrosis stage in patients with Fontan-associated liver disease
by: Tomomi Kogiso, et al.
Published: (2024-01-01)